IN2013MU02953A - - Google Patents

Download PDF

Info

Publication number
IN2013MU02953A
IN2013MU02953A IN2953MU2013A IN2013MU02953A IN 2013MU02953 A IN2013MU02953 A IN 2013MU02953A IN 2953MU2013 A IN2953MU2013 A IN 2953MU2013A IN 2013MU02953 A IN2013MU02953 A IN 2013MU02953A
Authority
IN
India
Prior art keywords
present
surface modified
therapeutic activity
targeted delivery
improved therapeutic
Prior art date
Application number
Other languages
English (en)
Inventor
Kamalinder Kaur Singh
Yogeeta Yeshwant Rajam
Sampada Shrikant Sawant
Aditi Abhay Sidhaye
Original Assignee
Kamalinder Kaur Singh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kamalinder Kaur Singh filed Critical Kamalinder Kaur Singh
Priority to IN2953MU2013 priority Critical patent/IN2013MU02953A/en
Publication of IN2013MU02953A publication Critical patent/IN2013MU02953A/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IN2953MU2013 2013-09-12 2013-09-12 IN2013MU02953A (enExample)

Priority Applications (1)

Application Number Priority Date Filing Date Title
IN2953MU2013 IN2013MU02953A (enExample) 2013-09-12 2013-09-12

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN2953MU2013 IN2013MU02953A (enExample) 2013-09-12 2013-09-12

Publications (1)

Publication Number Publication Date
IN2013MU02953A true IN2013MU02953A (enExample) 2015-07-10

Family

ID=54396206

Family Applications (1)

Application Number Title Priority Date Filing Date
IN2953MU2013 IN2013MU02953A (enExample) 2013-09-12 2013-09-12

Country Status (1)

Country Link
IN (1) IN2013MU02953A (enExample)

Similar Documents

Publication Publication Date Title
MX2020014300A (es) Compuestos heterociclicos utiles en el tratamiento de enfermedades.
MX350589B (es) Copolimeros funcionales pla-peg, las nanoparticulas de los mismos, su preparacion y su uso para la administracion dirigida de farmacos e imagenologia.
EP2894985A4 (en) PROGRAMMABLE ACTIVE COMPOUND PROFILES OF TUMORED BACTERIA
EP3047666A4 (en) Delivery of targeted media content
HRP20220897T8 (hr) Kombinirana terapija koja uključuje antitijela protiv klaudina 18.2 za liječenje raka
ZA201601443B (en) Administration of kynurenine depleting enzymes for tumor therapy
PL2968218T3 (pl) Skojarzenie do leczenia choroby parkinsona
IL233715A0 (en) Treatment of diseases related to the circadian rhythm
EP2968881B8 (en) Apparatus for delivery of medication to the brain to treat neurological conditions
EP3150202A4 (en) Drug carrier for tumour-specific targeted drug delivery and use thereof
EP4005604B8 (en) Delivery of drugs
IL236678A0 (en) Crystallin-alpha inhibitors for the treatment of cataracts
AU2016297823B2 (en) Methods for better delivery of active agents to tumors
IL249455A0 (en) Complexes of mineral-amino acids with active substances
EP2999461A4 (en) Targeted delivery of drugs to the myometrium
AU2014271207A1 (en) Targeted delivery of drugs to the myometrium
PH12016500863A1 (en) Tetracyclic autotaxin inhibitors
IN2013MU03918A (enExample)
EP3003489A4 (en) Cytotoxic agents for the treatment of cancer
MX2020009966A (es) Formas de dosificacion y usos terapeuticos de la l-4-cloro quinurenina.
IL248904A0 (en) Peptide-polypeptide composite nanoparticles for use in drug delivery
IL257983A (en) Improved transport of drugs into the brain
GB201419540D0 (en) Delivery of drugs
GB201410507D0 (en) Drug delivery enhancement agents
SG11201507254VA (en) Novel dosing regimens of celgosivir for the treatment of dengue